[Pneumocystis carinii infection. Various aspects on its clinical and laboratory diagnosis] NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Pneumocystis carinii infection. Various aspects on its clinical and laboratory diagnosis]

Rev Med Chil. 1992 Jun;120(6):634-7. Unique Identifier : AIDSLINE MED/94090063
Lorca M; Tassara R; Denegri M; Sierra P; Garcia A; Munoz P; Barria MS; Henriquez A; Caviedes I; Wu E; et al; Departamento de Pediatria, Facultad de Medicina (Division Cs.; Medicas Occidente) Universidad de Chile, Santiago.

Abstract: P carinii is an opportunistic pathogenic agent able to produce severe infection that must be diagnosed promptly. We analyzed 138 samples from 100 patients suspected of having infection by P carinii. The ortho-toluidine blue and the methenamine stains were used to analyze the samples. Infection was demonstrated in 18 patients, 13 adults and 5 children. Underlying disease was AIDS in 7 and other immunosuppressive disorders in the rest. No immunocompetent patient was infected with P carinii. Proper sample collection is important for diagnosis. When bronchoalveolar lavage is not possible, pharyngo-tracheal aspirate in children and sputum sampling after assisted coughing in adults are recommended. At least 2 staining methods and proper controls are advisable.
Keywords: Adult Aged Aged, 80 and over Child Child, Preschool English Abstract Female Human Infant Male Middle Age Pneumonia, Pneumocystis carinii/COMPLICATIONS/*DIAGNOSIS Support, Non-U.S. Gov't JOURNAL ARTICLEKWDadultagedaged,80andoverchildchild,preschoolenglishabstractfemalehumaninfantmalemiddleagepneumonia,pneumocystiscarinii/complications/KWDdiagnosissupport,non-uKWDsKWDgov'tjournalarticle
940330
M9431007

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .